Marking European Testing Week: ECDC issues integrated hepatitis and HIV testing Guidance
To mark European Testing Week from 23 to 30 November 2018, ECDC publishes its new Guidance on integrated viral hepatitis and HIV testing.
Expert panel reviews neuraminidase inhibitors for the prevention and treatment of influenza
An ECDC expert opinion concludes that there is clear evidence supporting the use of neuraminidase inhibitors in the treatment and prevention of influenza. Moreover, the current recommendations in European countries on the use of the neuraminidase inhibitors oseltamivir and zanamivir are appropriate and should be applied by prescribing physicians.
ECDC Observership programme 2016 for ESCMID and ESCV members
ECDC hosted observers from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the European Society for Clinical Virology (ESCV) in September for a week-long programme of seminars, activities and events under the ECDC Observership programme.
ECDC expert visit to Romania to discuss aspects related to healthcare-associated infections
A team of multidisciplinary experts, including ECDC staff and an expert from Norway, visited Romania between 4 and 7 July to discuss aspects related to the detection, surveillance, prevention and control of healthcare-associated infections (HAIs), together with staff at the Ministry of Health, the National Institute for Public Health and other Romanian stakeholders. This was an exploratory visit following a request for support made by the Romanian Minister of Health to tackle the challenges that the country was currently facing in this area.